Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Medtronic said it has received "no confirmed reports of unauthorized persons changing settings or controlling insulin delivery." Medtronic is recommending that diabetics who use the pump take ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

The recall affects pump systems from the MiniMed 600 and 700 lines of insulin pumps, and Medtronic has already reported 181 adverse events because of the defect. Insulin pumps are medical devices ...

Medtronic has received 170 reports of hyperglycaemia and 11 reports of diabetic ketoacidosis from January 2023 to September 2024 in the US, which it says is potentially related to this issue.

Sept 20 (Reuters) - The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic , opens new tab were vulnerable to cyberattacks and ...

Medtronic and the FDA left an insulin pump with a potentially deadly vulnerability on the market—until researchers who found the flaw showed how bad it could be.

The Medtronic pumps affected by the alert are: the MiniMed 508; MiniMed Paradigm models 511, 512/712, 712E, 515/715, 522/722, 522K/722K; plus Paradigm 523/723 and 523K/723K pumps with software ...

Medtronic’s MiniMed 640G marks another step forward for insulin pump technology as it features the SmartGuard algorithm which uses CGM data to predict and prevent hypos. The MiniMed 640G also marks ...

Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life. The Galway, Ireland-based ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...